Mark C. Schneyer insider trades

Open-market stock purchases and sales by Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER at Acadia Pharmaceuticals Inc, from SEC Form 4 filings since Feb 23, 2022.

Recent trades

DateStockTradeValue
Aug 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Aug 6, 2026ACAD Acadia Pharmaceuticals IncSold$145K
Aug 6, 2026ACAD Acadia Pharmaceuticals IncSold$273K
Aug 5, 2026ACAD Acadia Pharmaceuticals IncSold$170K
Aug 5, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
May 4, 2026ACAD Acadia Pharmaceuticals IncSold$76.4K
May 1, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Apr 7, 2026ACAD Acadia Pharmaceuticals IncSold$60.1K
Apr 5, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 26, 2026ACAD Acadia Pharmaceuticals IncSold$68.7K
Mar 26, 2026ACAD Acadia Pharmaceuticals IncSold$804
Mar 25, 2026ACAD Acadia Pharmaceuticals IncSold$89.7K
Mar 25, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 24, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Mar 6, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
Nov 18, 2025ACAD Acadia Pharmaceuticals IncSold$243K
Nov 17, 2025ACAD Acadia Pharmaceuticals IncBought (not open market)—

Companies traded

  • ACAD Acadia Pharmaceuticals Inc: 31 sales, last Aug 6, 2026

Get free alerts when Mark C. Schneyer files a new trade →